1. Home
  2. LITE vs RVMD Comparison

LITE vs RVMD Comparison

Compare LITE & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lumentum Holdings Inc.

LITE

Lumentum Holdings Inc.

HOLD

Current Price

$898.00

Market Cap

24.1B

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$94.96

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITE
RVMD
Founded
2015
2014
Country
United States
United States
Employees
N/A
883
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.1B
19.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
LITE
RVMD
Price
$898.00
$94.96
Analyst Decision
Buy
Strong Buy
Analyst Count
15
17
Target Price
$637.21
$120.47
AVG Volume (30 Days)
5.7M
1.6M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
104.56
N/A
EPS
0.99
N/A
Revenue
$1,247,700,000.00
N/A
Revenue This Year
$79.03
N/A
Revenue Next Year
$63.02
$411.49
P/E Ratio
$902.34
N/A
Revenue Growth
24.57
N/A
52 Week Low
$49.13
$34.00
52 Week High
$960.00
$124.49

Technical Indicators

Market Signals
Indicator
LITE
RVMD
Relative Strength Index (RSI) 64.79 45.23
Support Level $549.99 $93.39
Resistance Level N/A $101.00
Average True Range (ATR) 66.76 3.12
MACD 14.10 0.13
Stochastic Oscillator 81.42 37.66

Price Performance

Historical Comparison
LITE
RVMD

About LITE Lumentum Holdings Inc.

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: